The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 03, 2019
Filed:
Dec. 08, 2016
Applicant:
Wista Laboratories Ltd., Singapore, SG;
Inventors:
Scott Clunas, Old Aberdeen, GB;
John Mervyn David Storey, Old Aberdeen, GB;
Janet Elizabeth Rickard, Aberdeen, GB;
David Horsley, Aberdeen, GB;
Charles Robert Harrington, Aberdeen, GB;
Claude Michel Wischik, Aberdeen, GB;
Assignee:
WISTA LABORATORIES LTD., Singapore, SG;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 311/82 (2006.01); C07D 335/12 (2006.01); C07D 241/46 (2006.01); C07D 265/38 (2006.01); C07D 311/90 (2006.01); C07D 491/22 (2006.01); C07D 493/16 (2006.01); A61K 31/352 (2006.01); A61K 31/382 (2006.01); A61K 31/4545 (2006.01); A61K 31/4745 (2006.01); A61K 31/498 (2006.01); A61K 31/5377 (2006.01); A61K 31/538 (2006.01); A61K 45/06 (2006.01); C07D 491/16 (2006.01); G01N 33/68 (2006.01); A61K 9/00 (2006.01); A61K 31/4025 (2006.01); A61K 49/00 (2006.01); C09B 11/24 (2006.01); C09B 11/28 (2006.01); C09B 17/00 (2006.01); C09B 19/00 (2006.01); C09B 21/00 (2006.01); C09B 57/00 (2006.01); C07D 311/84 (2006.01); C07D 335/14 (2006.01); C07D 335/20 (2006.01);
U.S. Cl.
CPC ...
C07D 311/82 (2013.01); A61K 9/0053 (2013.01); A61K 31/352 (2013.01); A61K 31/382 (2013.01); A61K 31/4025 (2013.01); A61K 31/4545 (2013.01); A61K 31/4745 (2013.01); A61K 31/498 (2013.01); A61K 31/538 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); A61K 49/00 (2013.01); C07D 241/46 (2013.01); C07D 265/38 (2013.01); C07D 311/90 (2013.01); C07D 335/12 (2013.01); C07D 491/16 (2013.01); C07D 491/22 (2013.01); C07D 493/16 (2013.01); C09B 11/24 (2013.01); C09B 11/28 (2013.01); C09B 17/00 (2013.01); C09B 19/00 (2013.01); C09B 21/00 (2013.01); C09B 57/00 (2013.01); G01N 33/6896 (2013.01); C07D 311/84 (2013.01); C07D 335/14 (2013.01); C07D 335/20 (2013.01); G01N 2800/7047 (2013.01);
Abstract
Described are a compound of formula (II) or (III): The compounds are effective in the treatment of disease, including a tauopathy condition or a disease of tau protein aggregation.